Literature DB >> 11267185

ISA(TX)247: a novel calcineurin inhibitor.

L Aspeslet1, D Freitag, D Trepanier, M Abel, S Naicker, N Kneteman, R Foster, R Yatscoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267185     DOI： 10.1016/s0041-1345(00)02325-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  14 in total

Review 1.  Emerging therapeutic options for atopic dermatitis: beyond TIMs.

Authors:  Edward R Conner; Lisa A Beck
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

Review 2.  Emerging drugs for uveitis.

Authors:  Theresa Larson; Robert B Nussenblatt; H Nida Sen
Journal:  Expert Opin Emerg Drugs       Date:  2011-01-06       Impact factor: 4.191

3.  Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Authors:  Aswani Dutt Vadlapudi; Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Recent Pat Biomed Eng       Date:  2012-04-01

4.  Identification of a cyclosporine-specific P450 hydroxylase gene through targeted cytochrome P450 complement (CYPome) disruption in Sebekia benihana.

Authors:  Mi-Jin Lee; Hyun-Bum Kim; Yeo Joon Yoon; Kyuboem Han; Eung-Soo Kim
Journal:  Appl Environ Microbiol       Date:  2013-01-25       Impact factor: 4.792

5.  LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.

Authors:  Matthew A Cunningham; Bobbie Ann Austin; Zhuqing Li; Baoying Liu; Steven Yeh; Chi-Chao Chan; Eddy Anglade; Poonam Velagaleti; Robert B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

6.  Structural basis for the cyclophilin A binding affinity and immunosuppressive potency of E-ISA247 (voclosporin).

Authors:  Andreas Kuglstatter; Francis Mueller; Eric Kusznir; Bernard Gsell; Martine Stihle; Ralf Thoma; Joerg Benz; Launa Aspeslet; Derrick Freitag; Michael Hennig
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-01-15

7.  NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.

Authors:  R J Flockhart; J L Armstrong; N J Reynolds; P E Lovat
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

8.  Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?

Authors:  Matthias Sieber; Ria Baumgrass
Journal:  Cell Commun Signal       Date:  2009-10-27       Impact factor: 5.712

Review 9.  Calcineurin inhibitors: a double-edged sword.

Authors:  Adaku C Ume; Tara-Yesomi Wenegieme; Clintoria R Williams
Journal:  Am J Physiol Renal Physiol       Date:  2020-11-23

10.  Voclosporin as a treatment for noninfectious uveitis.

Authors:  Clyde Schultz
Journal:  Ophthalmol Eye Dis       Date:  2013-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.